MarketSmith India, a stock research platform, has released its stock recommendations for October 30, 2025. Here's a summary of their picks, blending insights from available reports:

Motilal Oswal Recommendations

Motilal Oswal, a financial services company, has highlighted MarketSmith India's stock picks for today.

• Colgate-Palmolive (India) Ltd: Recommended as a buy at ₹2,508, with a target price of ₹2,890 within three months and a stop loss at ₹2,310.
• United Spirits: Another buy recommendation at ₹1,451, targeting ₹1,650 in three months, with a stop loss at ₹1,370.
• Hikal Ltd: Current market price is ₹403.75. It is recommended to buy at ₹395-405, with a profit goal of ₹475 and a stop loss at ₹365. The timeframe is 2-3 months.
• Shilpa Medicare Ltd: Current market price is ₹873.25. It is recommended to buy at ₹860-875, with a profit goal of ₹1,040 and a stop loss at ₹808. The timeframe is 2-3 months.
• Azad Engineering Ltd: Current market price is ₹1,579.05. It is recommended to buy at ₹1,550-1,580, with a profit goal of ₹1890 and a stop loss at ₹1,427. The timeframe is 1-2 months.

Earlier Recommendations

These recommendations were made earlier in October:

• IDBI Bank Ltd (October 24): With a current price of ₹95, it was recommended due to strong parent backing from LIC and the government, improving asset quality, consistent profitability, a focus on retail lending and digital banking, and improved efficiency. Key metrics included a P/E of 12.85 and a 52-week high of ₹106.32. The buy range was ₹95–97, with a target price of ₹110 in two to three months and a stop loss at ₹90.
  • Risk factors: Potential delays in privatization, exposure to stressed sectors, interest rate fluctuations, and regulatory risks.
• Multi Commodity Exchange of India Limited (October 24): At a current price of ₹9,259, the recommendation was based on an expanding product suite and higher derivatives participation. The buy range was ₹9,250–9,350, with a target price of ₹9,900 in two to three months and a stop loss at ₹9,030.
  • Risk factors: Commodity vulnerability, volume cyclicality, and concentration risk.
• Tilaknagar Industries Ltd (October 23): At a current price of ₹488, it was recommended based on premiumization, volume expansion, and market share gains. The buy range was ₹480–490, with a target price of ₹550 in two to three months and a stop loss at ₹464.
  • Risk factors: Brand acquisition and execution risk, competitive pressure, and modest product growth.
• Delhivery Ltd (October 23): At a current price of ₹475, the recommendation cited a scaled, automated network. The buy range was ₹470–478, with a target price of ₹540 in two to three months and a stop loss at ₹446.
  • Risk factors: Commodity/fuel, FX, and interest-rate exposure, pricing pressure, and competitive intensity.
• Apollo Hospitals Enterprise Limited (October 15): Specifics on the recommendation price and targets are not provided in the available snippets.

Market Performance and Influences

On October 24, the Indian benchmark indices showed modest gains, marking a sixth consecutive session of increases, although profit-booking trimmed an early rally. The Nifty 50 closed at 25,891.40, up 0.09%, and the Sensex at 84,556.40, up 0.15%. Earlier, on October 3rd, the Nifty 50 surged 239 points (0.97%) to settle above the key technical resistance at 24,850.6, while the Sensex gained 754 points, closing at 81,022.58. Optimism around a potential India-US trade deal and sustained buying from foreign institutional investors (FIIs) largely fueled the market's early surge. The IT index was a strong performer, driven by gains in companies like Infosys after its buyback announcement; however, the narrow focus of the rally suggests some caution.

Disclaimer: It's important to remember that these are merely recommendations. Investors should conduct their own thorough research and due diligence before making any investment decisions. MarketSmith India emphasizes that investment in equities is subject to market risks, and past performance is not indicative of future results.